Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
16.96
+2.33 (15.93%)
At close: Nov 4, 2024, 4:00 PM
16.90
-0.06 (-0.35%)
After-hours: Nov 4, 2024, 5:53 PM EST

Monopar Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2015
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2015
Net Income
-7.12-8.4-10.52-9.1-6.3-4.22
Upgrade
Stock-Based Compensation
1.611.91.641.471.321.01
Upgrade
Other Operating Activities
-----0.12-
Upgrade
Change in Accounts Payable
-1.37-1.331.480.40.450.24
Upgrade
Change in Other Net Operating Assets
0.06-0.020.17-0.09-0-0.05
Upgrade
Operating Cash Flow
-6.82-7.86-7.23-7.32-4.66-3.02
Upgrade
Investment in Securities
1.974.93-4.92---
Upgrade
Investing Cash Flow
1.974.93-4.92---
Upgrade
Long-Term Debt Issued
----0.12-
Upgrade
Net Debt Issued (Repaid)
----0.12-
Upgrade
Issuance of Common Stock
3.792.070.1111.288.4310.33
Upgrade
Repurchase of Common Stock
-0.03-0.05-0.08-0.06--
Upgrade
Other Financing Activities
----0.34-0.37-0.98
Upgrade
Financing Cash Flow
3.752.030.0310.888.189.35
Upgrade
Foreign Exchange Rate Adjustments
-0-0.02-000-0.01
Upgrade
Net Cash Flow
-1.09-0.92-12.123.573.526.32
Upgrade
Free Cash Flow
-6.82-7.86-7.23-7.32-4.66-3.02
Upgrade
Free Cash Flow Per Share
-2.19-2.84-2.84-2.93-2.13-1.62
Upgrade
Cash Income Tax Paid
-----0.010
Upgrade
Levered Free Cash Flow
-4.43-5.01-3.22-3.99-2.34-1.02
Upgrade
Unlevered Free Cash Flow
-4.43-5.01-3.22-3.99-2.34-1.02
Upgrade
Change in Net Working Capital
1.361.39-1.72-0.25-0.41-0.67
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.